ALKBH5 and colorectal carcinoma: The FTO-ALKBH5/IGF2BP2-m6A axis mediates the stabilization of HK2 mRNA, leading to the downregulation of HK2 expression, which restrains the FOXO signaling pathway to suppress CRC progression (27).